NASDAQ:ZLTQ - (ZLTQ) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$56.48
+0.30 (1.20%)
Get New (ZLTQ) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZLTQ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZLTQ

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for (ZLTQ) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $56.48.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in (ZLTQ). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/24/2017AegisReiterated RatingHold$56.00Low
i
3/10/2017Canaccord GenuityReiterated RatingHold$56.50N/A
i
3/2/2017Stifel NicolausDowngradeBuy ➝ HoldN/A
i
2/21/2017Canaccord GenuityReiterated RatingHold$56.50N/A
i
2/14/2017Northcoast ResearchDowngradeBuy ➝ NeutralN/A
i
Rating by E. Snyder at Northcoast Research
2/14/2017SVB LeerinkDowngradeOutperform ➝ Market PerformN/A
i
Rating by R. Newitter at SVB Leerink LLC
2/14/2017AegisDowngradeBuy ➝ Hold$51.00N/A
i
2/13/2017William BlairDowngradeOutperform ➝ Market PerformN/A
i
Rating by M. Kaczor at William Blair
2/13/2017Canaccord GenuityDowngradeBuy ➝ HoldN/A
i
2/13/2017Maxim GroupDowngradeBuy ➝ HoldN/A
i
2/13/2017Northland SecuritiesReiterated RatingPositiveN/A
i
2/13/2017Piper Jaffray CompaniesDowngradeOverweight ➝ NeutralN/A
i
1/23/2017Canaccord GenuityReiterated RatingBuy$45.00N/A
i
1/4/2017Maxim GroupBoost Price TargetBuy$48.00 ➝ $58.00N/A
i
12/7/2016AegisInitiated CoverageBuy$51.00N/A
i
11/10/2016Canaccord GenuityBoost Price TargetBuy$41.00 ➝ $45.00N/A
i
11/8/2016Northcoast ResearchReiterated RatingBuyN/A
i
Rating by E. Snyder at Northcoast Research
10/24/2016Brean CapitalReiterated RatingBuyN/A
i
Rating by Difei Yang at Brean Capital
9/21/2016Stifel NicolausBoost Price TargetBuy$38.00 ➝ $52.00N/A
i
8/25/2016SVB LeerinkReiterated RatingOutperform$48.00N/A
i
Rating by Richard Newitter at SVB Leerink LLC
8/11/2016SVB LeerinkReiterated RatingOutperform$43.00 ➝ $48.00N/A
i
Rating by Richard Newitter at SVB Leerink LLC
8/9/2016JPMorgan Chase & Co.Reiterated RatingHold$27.00 ➝ $35.00N/A
i
8/9/2016Brean CapitalSet Price TargetBuy$35.00 ➝ $39.00N/A
i
Rating by Difei Yang at Brean Capital
8/9/2016Maxim GroupBoost Price TargetBuy$40.00 ➝ $48.00N/A
i
Rating by Anthony Vendetti at Maxim Group
7/13/2016SVB LeerinkReiterated RatingOutperform$43.00N/A
i
Rating by Richard Newitter at SVB Leerink LLC
6/30/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Richard Newitter at SVB Leerink LLC
6/21/2016Brean CapitalReiterated RatingBuy$35.00N/A
i
Rating by Difei Yang at Brean Capital
(Data available from 6/14/2016 forward)
(ZLTQ) logo
ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company's product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.
Read More

Today's Range

Now: $56.48
$56.48
$56.48

50 Day Range

MA: N/A

52 Week Range

Now: $56.48
$23.58
$56.50

Volume

N/A

Average Volume

1,527,824 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of (ZLTQ)?

The following Wall Street sell-side analysts have issued reports on (ZLTQ) in the last twelve months:
View the latest analyst ratings for ZLTQ.

What is the current price target for (ZLTQ)?

0 Wall Street analysts have set twelve-month price targets for (ZLTQ) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for (ZLTQ) in the next year.
View the latest price targets for ZLTQ.

What is the current consensus analyst rating for (ZLTQ)?

(ZLTQ) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ZLTQ.

What other companies compete with (ZLTQ)?

How do I contact (ZLTQ)'s investor relations team?

(ZLTQ)'s physical mailing address is 4410 Rosewood Dr, PLEASANTON, CA 94588-3050, United States. The medical equipment provider's listed phone number is +1-925-4742500. The official website for (ZLTQ) is www.coolsculpting.com.